We are pleased to announce the 13th International Conference on Nephrology & Therapeutics , to be held on October 14-15, 2024, in London, UK. This premier event brings together leading experts, researchers, healthcare professionals, and industry pioneers from around the globe to explore the most recent advancements and innovations in the field of Nephrology.
Under the theme “Kidney Health for All - Advancing Equitable Access to Care and Optimal Medication Practice,” Nephrology 2024 will provide a comprehensive platform for discussing the critical challenges in kidney care, from prevention and diagnosis to treatment and post-therapeutic care. With a focus on bridging disparities in healthcare access, the conference aims to foster collaboration and innovative approaches to ensure that high-quality nephrology care and effective medication management reach all patients, irrespective of their geographic or socioeconomic background.
This conference will cover a broad spectrum of topics, including but not limited to:
-
Advances in chronic kidney disease management
-
Innovations in dialysis and renal transplantation
-
Precision medicine and personalized treatment in nephrology
-
Pharmacological advancements in kidney care
-
Addressing global challenges in equitable healthcare delivery
Nephrology 2024 offers a unique opportunity for professionals to exchange knowledge, share experiences, and engage in thought-provoking discussions on the latest research and clinical practices. Attendees will also benefit from networking sessions designed to foster collaborations between academia, healthcare providers, and the pharmaceutical industry.
Join us in London to be a part of this groundbreaking event dedicated to improving kidney health and advancing therapeutic approaches for all.
This track focuses on the rapid loss of kidney function, which can result from various causes such as injury, infection, or toxins. Topics include pathophysiology, diagnostic approaches, management strategies, and preventive measures for acute kidney injury (AKI). Attendees will learn about the latest research and clinical practices to improve patient outcomes.
Precision medicine involves tailoring medical treatment to the individual characteristics of each patient. This track covers genomics, biomarkers, and personalized treatment plans in nephrology. Discussions will highlight how precision medicine can improve diagnosis, treatment, and patient care in kidney diseases, along with ethical considerations and future directions.
This track delves into the latest innovations in dialysis technology, including hemodialysis and peritoneal dialysis. Topics include new machines, techniques, and patient comfort improvements. Participants will explore how these advancements can enhance the quality of life for dialysis patients and what future trends are on the horizon.
Chronic Kidney Disease (CKD) requires ongoing management and innovative treatments. This track discusses novel pharmacological treatments, regenerative medicine, lifestyle modifications, and integrative approaches. Attendees will gain insights into emerging therapies that can slow CKD progression and improve patient outcomes.
This track addresses the practical aspects of nephrology practice, including best practices, managing comorbidities, advances in clinical trials, and case studies. It aims to provide healthcare professionals with the latest knowledge and tools to enhance patient care and clinical practice in nephrology.
Renal transplantation is a critical area of nephrology with unique challenges and continuous innovations. This track explores overcoming barriers, advances in immunosuppressive therapy, post-transplant care, and ethical and legal issues. It offers a comprehensive overview of the latest developments and future prospects in renal transplantation.
Medication management is crucial for kidney disease patients. This track covers pharmacokinetics, adverse drug reactions, drug development, and medication adherence. Attendees will learn about current and emerging medications, their effects, and best practices for managing kidney disease pharmacologically.
Telemedicine and remote monitoring have become vital in nephrology, especially post-pandemic. This track discusses the implementation, technologies, impact on patient outcomes, and future directions of telehealth in nephrology. It aims to show how remote care can be integrated into nephrology practices to improve accessibility and efficiency.
Kidney health disparities exist worldwide, and this track provides a global view of nephrology. Topics include international initiatives, cultural considerations, health disparities, and collaborations in research. Participants will gain insights into global kidney health issues and strategies for improving care worldwide.
Hydronephrosis involves the swelling of a kidney due to urine build-up. This track covers its etiology, pathogenesis, diagnostic techniques, treatment options, and long-term management. Attendees will explore current research and clinical practices to effectively manage hydronephrosis.
This track focuses on all aspects of kidney transplantation, from donor selection and surgical techniques to managing rejection and long-term patient care. It provides a comprehensive view of the transplantation process, innovations, and strategies to improve transplant success rates and patient quality of life.
Neuro-urology addresses neurological conditions affecting the urinary system. Topics include the diagnosis and management of neurogenic bladder, neurological disorders impacting the urinary system, and advances in neuro-urological treatments. This track emphasizes interdisciplinary approaches and innovative therapies in neuro-urology.
Pediatric nephrology is dedicated to kidney disorders in children. This track covers congenital kidney disorders, pediatric renal transplantation, growth and development in children with kidney disease, and innovative therapies. It aims to provide knowledge and strategies for managing kidney diseases in the pediatric population.
Accurate diagnosis and comprehensive care are vital in nephrology. This track covers advances in diagnostic imaging, laboratory tests, biomarkers, comprehensive care models, and patient-centered care approaches. Attendees will learn about the latest diagnostic techniques and holistic care strategies.
Renal replacement therapy (RRT) is essential for patients with severe kidney failure. This track discusses hemodialysis, peritoneal dialysis, innovations, improving patient outcomes, and future prospects in RRT. It provides a detailed understanding of current practices and future trends in renal replacement.
COVID-19 has had significant impacts on the renal system. This track explores acute kidney injury in COVID-19 patients, long-term renal sequelae, managing CKD patients during the pandemic, and recent research findings. It aims to provide comprehensive insights into the interplay between COVID-19 and kidney health.
Urology is closely related to nephrology, dealing with the urinary tract and male reproductive organs. This track covers advances in urological surgery, urological cancers, managing urological disorders in kidney patients, and innovations in urological instrumentation and techniques. It offers a broad view of current trends and future directions in urology.
The global kidney function tests market was worth USD 845.9 million last year and is expected to grow at a compound annual growth rate (CAGR) of 6.50% between 2023 and 2030. Increasing market player investments, rising R&D activities, high prevalence of kidney diseases, rising government initiatives, and technological innovations are expected to drive market growth significantly. For an example, Nova Biomedical launched a novel tool in March 2022 to advance kidney care through early disease detection and renal function screening in Point - of - care testing technologies outside the hospital. The company's technology has been validated in clinical studies conducted in non-hospital settings such as Read more..
The Nephrology and Therapeutics sector is currently experiencing dynamic growth, driven by increasing prevalence of chronic kidney disease (CKD) and hypertension, advances in dialysis technologies, and significant progress in kidney transplantation techniques. The global nephrology therapeutics market is projected to exceed $16 billion by 2025, with a robust compound annual growth rate (CAGR). This growth is fueled by heightened awareness of kidney health, the development of novel therapeutics, and increasing investment in research and innovation.
London, a city renowned for its world-class healthcare infrastructure and cutting-edge research facilities, is an ideal venue for this conference. The city's strategic location and rich history in medical advancements make it a prime destination for nephrology professionals to gather, exchange ideas, and push the boundaries of Kidney Care.
Societies & Affiliations
This enhanced content provides a comprehensive and engaging overview of the "13th International Conference on Nephrology & Therapeutics," helping to attract a wide range of participants and stakeholders.
Jorge Moises Sandrus
Luigi Masoni
Dr. med. Katrin Ivens
Dr. med. Martin K. Kuhlmann
Dr. Doubravka Frausova
Alexander Wiseman
Dr. Martin L. Mai
